Cargando…
Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications
INTRODUCTION: Drug repurposing can be a successful approach to deal with the scarcity of cost-effective therapies in situations such as the COVID-19 pandemic. Tetracyclines have previously shown efficacy in preclinical acute respiratory distress syndrome (ARDS) models and initial predictions and exp...
Autores principales: | Garrido-Mesa, Jose, Adams, Kate, Galvez, Julio, Garrido-Mesa, Natividad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115781/ https://www.ncbi.nlm.nih.gov/pubmed/35294307 http://dx.doi.org/10.1080/13543784.2022.2054325 |
Ejemplares similares
-
Editorial: The gut-immune axis: a complex training ground impacting inflammatory pathologies
por: Garrido-Mesa, Jose, et al.
Publicado: (2023) -
Prospects of Novel and Repurposed Immunomodulatory Drugs against Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 Disease
por: Nayak, Smruti Sudha, et al.
Publicado: (2023) -
Measles-induced respiratory distress, air-leak and ARDS
por: Piastra, M., et al.
Publicado: (2009) -
Kratom-Induced Acute Respiratory Distress Syndrome (ARDS)
por: Chinnappan, Justine, et al.
Publicado: (2023) -
Predictors of survival in critically ill patients with acute respiratory distress syndrome (ARDS): an observational study
por: Balzer, Felix, et al.
Publicado: (2016)